Anti-Von Willebrand Factor antibody (ab6994)
- Datasheet
- References (195)
- Protocols
Overview
-
Product nameAnti-Von Willebrand Factor antibody
See all Von Willebrand Factor primary antibodies -
DescriptionRabbit polyclonal to Von Willebrand Factor
-
Host speciesRabbit
-
Tested applicationsSuitable for: ICC/IF, IHC-FrFl, IHC-P, IHC-Fr, WB, Flow Cyt, IHC-FoFrmore details
-
Species reactivityReacts with: Rat, Sheep, Horse, Guinea pig, Cow, Dog, Human, Pig
Does not react with: Chicken -
Immunogen
Full length native protein (purified) corresponding to Human Von Willebrand Factor. Purified from plasma.
-
Positive control
- IHC-P: Pig skin tissue; BCG infected guinea pig lung tissue. ICC/IF: Equine exuberant granulation cells
-
General notes
Abcam recommended secondaries - Goat Anti-Rabbit HRP (ab205718) and Goat Anti-Rabbit Alexa Fluor® 488 (ab150077).
See other anti-rabbit secondary antibodies that can be used with this antibody.
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
-
Storage bufferpH: 7.4
Preservative: 0.097% Sodium azide
Constituent: PBS -
Concentration information loading... -
PurityIgG fraction
-
Purification notesWhole antiserum is fractionated and then further purified by ion exchange chromatography to provide the IgG fraction of antiserum. This fraction is essentially free of other rabbit serum proteins.
-
ClonalityPolyclonal
-
IsotypeIgG
-
Research areas
Associated products
-
Alternative Products
- Anti-Von Willebrand Factor antibody [EPSISR15] (ab154193)
- Anti-Von Willebrand Factor antibody [EPR12011] (ab174290)
- Anti-Von Willebrand Factor antibody [EPR12010] (ab179451)
- Anti-Von Willebrand Factor antibody [EPR2992(N)] (ab181871)
- Anti-Von Willebrand Factor antibody [EPSISR15] (Alexa Fluor® 488) (ab195028)
- Anti-Von Willebrand Factor antibody [EPSISR15] (Alexa Fluor® 647) (ab195029)
- Anti-Von Willebrand Factor antibody [EPSISR15] (HRP) (ab195030)
-
Compatible Secondaries
-
Isotype control
-
Related Products
Applications
Our Abpromise guarantee covers the use of ab6994 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| ICC/IF | 1/400. | |
| IHC-FrFl | 1/200. (see Abreview) | |
| IHC-P | 1/200 - 1/400. for IF and 1/1000-1/2000 for ABC methods with HRP conjugates. Perform enzymatic antigen retrieval with 0.1% pronase for 10 min at 35 °C before commencing with IHC protocol. Indirect Immunofluorescence: minimum working dilution of 1:200 was determined using FFPE sections of human tongue with FITC-conjugated secondary. Indirect Immunoperoxidase Labeling: minimum working dilution of 1:800 was determined using FFPE sections of human tongue with biotinylated secondary and signal amplification. | |
| IHC-Fr | 1/1000. | |
| WB | 1/500. | |
| Flow Cyt | Use a concentration of 5 µg/ml. ab171870 - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody. |
|
| IHC-FoFr | Use at an assay dependent concentration. PubMed: 19622235 |
Target
-
FunctionImportant in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.
-
Tissue specificityPlasma.
-
Involvement in diseaseDefects in VWF are the cause of von Willebrand disease (VWD) [MIM:277480]. VWD defines a group of hemorrhagic disorders in which the von Willebrand factor is either quantitatively or qualitatively abnormal resulting in altered platelet function. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII and impaired platelet adhesion. Type I von Willebrand disease is the most common form and is characterized by partial quantitative plasmatic deficiency of an otherwise structurally and functionally normal Willebrand factor; type II is associated with a qualitative deficiency and functional anomalies of the Willebrand factor; type III is the most severe form and is characterized by total or near-total absence of Willebrand factor in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII.
-
Sequence similaritiesContains 1 CTCK (C-terminal cystine knot-like) domain.
Contains 4 TIL (trypsin inhibitory-like) domains.
Contains 3 VWFA domains.
Contains 3 VWFC domains.
Contains 4 VWFD domains. -
DomainThe von Willebrand antigen 2 is required for multimerization of vWF and for its targeting to storage granules.
-
Post-translational
modificationsAll cysteine residues are involved in intrachain or interchain disulfide bonds.
N- and O-glycosylated. -
Cellular localizationSecreted. Secreted > extracellular space > extracellular matrix. Localized to storage granules.
- Information by UniProt
-
Database links
- Entrez Gene: 7450 Human
- Entrez Gene: 116669 Rat
- Omim: 613160 Human
- SwissProt: P04275 Human
- SwissProt: Q62935 Rat
- Unigene: 440848 Human
- Unigene: 35561 Rat
-
Alternative names
- Coagulation factor VIII antibody
- Coagulation factor VIII VWF antibody
- F8VWF antibody
see all
Images
-
Immunocytochemistry/ Immunofluorescence - Anti-Von Willebrand Factor antibody (ab6994)Immunocytochemical analysis labeling Von Willebrand Factor in equine exuberant granulation cells with ab6994 at 1/100 dilution.
The nuclear counterstain is DAPI(blue)
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Von Willebrand Factor antibody (ab6994)This image is courtesy of an anonymous Abreviewab6994 staining Von Willebrand Factor in pig skin tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 3% serum for 30 minutes at 20°C; antigen retrieval was enzymatic using pronase, 1mg/ml. Samples were incubated with primary antibody (1/500 in PBS) for 12 hours at 4°C. A Biotin-conjugated goat anti-rabbit IgG polyclonal (1/200) was used as the secondary antibody.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Von Willebrand Factor antibody (ab6994)This picture shows Factor VII Immunohistochemical localization in BCG infected Guinea Pig Lung. The image was kindly supplied as part of the review submitted by Elizabeth Chlipala.
Protocols
References
This product has been referenced in:
- Danzl K et al. Early inhibition of endothelial retinoid uptake upon myocardial infarction restores cardiac function and prevents cell, tissue, and animal death. J Mol Cell Cardiol 126:105-117 (2019). Read more (PubMed: 30472251) »
- Peruzzotti-Jametti L et al. Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation. Cell Stem Cell 22:355-368.e13 (2018). Read more (PubMed: 29478844) »
